105
Participants
Start Date
October 1, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Radiotherapy
59.92Gy and 2.14Gy in 28 fractions to PGTV and 50.4Gy and 1.8Gy in 28 fractions 5 days every week in 5.5 weeks.
Albumin-Bound Paclitaxel
100mg/d weekly,repeatedly on the first day,by intravenous infusion in 5-6 weeks.
Cisplatin
25mg/m2 weekly,by intravenous infusion in 5-6 weeks.
RECRUITING
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing
RECRUITING
Department of Radiation oncology, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The affiliated Cancer Hospital of Nanjing Medical University, Nanjing
RECRUITING
Department of Radiation oncology, Jiangsu Province Hospital/The First Affiliated Hospital with Nanjing Medical University, Nanjing
RECRUITING
Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha
RECRUITING
Department 4th of Radiation Oncology, Anyang Cancer Hospital, Anyang
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER